Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Jasper Therapeutics, Inc.(JSPR) | 928,964 | 928,964 | 0 | $17.47M | $19.86M | 38.83% | +$2.39M |
| Tourmaline Bio Inc | 741,691 | 741,691 | 0 | $19.07M | $15.04M | 29.41% | -$4.03M |
| Korro Bio, Inc.(KRRO) | 368,085 | 368,085 | 0 | $12.30M | $14.01M | 27.40% | +$1.71M |
| Ventyx Biosciences Inc | 412,225 | 412,225 | 0 | $898.7K | $902.8K | 1.77% | +$4.1K |
| Hillevax Inc | 558,923 | 372,615 | -186,308 | $983.7K | $771.3K | 1.51% | -$212.4K |
| Kezar Life Sciences Inc COM NEW | 0 | 82,871 | +82,871 | $0 | $556.9K | 1.09% | +$556.9K |
| Kezar Life Sciences Inc | 828,711 | 0 | -828,711 | $638.1K | $0 | — | -$638.1K |